Study Complete
Sponsor ID
20120274

An Open-label, Randomized, Single-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 785 Administered as a Single 3-mL (70 mg/mL) Subcutaneous Infusion or Three 1-mL Pre-filled Syringe Injections (70 mg/mL) in Healthy Subjects and to Characterize the Inline Pressure of a 3-mL Subcutaneous Infusion of AMG 785 in Older Women

Sponsor ID
20120274
Clinicaltrials.gov ID
N/A
EUCTIS ID
N/A
EudraCT ID
N/A

Study Details

Additional Study Details

Phase
Phase 1
Product
AMG 785
Type
Interventional
Masking
N/A
Enrollment
N/A
Additional Study Details

Protocol Summary

Primary Outcome Measures
Not Available
Secondary Outcome Measures
Not Available

Study Documents

Study Synopsis
Available Language(s): English

Locations

Location
Status
Contact Us
Location
Research Site
Glendale, CA, United States, 91206
Status
Recruiting
Location
Research Site
Omaha, NE, United States, 68154
Status
Recruiting